VivoSeq
Other

Aspirin

0

Pipeline Programs↗

5

Active Trials↗

9

Companies Involved↗

Aspirin is an early-stage landscape with 0 programs across 9 companies. The most active players are Bayer, PLx Pharma, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

0 programs

PreclinicalP

PLx Pharma

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalR

Rhoshan Pharmaceuticals Inc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

69

clinical trials

Completed47 · 68%
Unknown status10 · 14%
Terminated7 · 10%
Recruiting3 · 4%
Not yet recruiting1 · 1%
Active, not recruiting1 · 1%

Clinical Trials

Trial Activity

69 trials

NSAIDs vs. Coxibs in the Presence of Aspirin
Recruiting·IInova Health Care Services·Phase 4·NCT03699293·30 enrolled
Trial to Determine Effective Aspirin Dose in COPD
Recruiting·JJohns Hopkins University·Phase 3·NCT05265299·48 enrolled
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Recruiting·TThomas Jefferson University·Phase 1/2·NCT06826859·400 enrolled
ASPIRIN Trial Belgium
Active, not recruiting·UUniversity Hospital, Antwerp·Phase 3·NCT03464305·148 enrolled
Timed Aspirin Chronobiome Study
Not yet recruiting·UUniversity of Pennsylvania·Phase 1·NCT03590821·60 enrolled
Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
Completed·UUniversity of Cape Town·Phase 2·NCT03927313·52 enrolled
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
Completed·FFundacion GESICA·Phase 4·NCT00793754·30 enrolled
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients
Completed·PPLx Pharma·Phase 3·NCT01515657·40 enrolled
Aspirin in Reduction of Tension II Study
Completed·LLeiden University Medical Center·Phase 4·NCT01379079·290 enrolled
Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin
Completed·IInova Health Care Services·Phase 1·NCT04328883·19 enrolled
Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex
Completed·PPLx Pharma·Phase 1·NCT04008979·32 enrolled
Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU
Completed·Bayer logoBayer·N/A·NCT03904732·2,000,000 enrolled
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
Completed·HHamilton Health Sciences Corporation·N/A·NCT03424408·20 enrolled
A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets
Completed·Bayer logoBayer·Phase 1·NCT03225352·12 enrolled
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
Completed·—·N/A·NCT02697916·15,076 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)